Free Trial
OTCMKTS:NVZMF

Novozymes A/S (NVZMF) Stock Price, News & Analysis

Novozymes A/S logo
$57.26 -0.84 (-1.45%)
As of 02:16 PM Eastern

About Novozymes A/S Stock (OTCMKTS:NVZMF)

Key Stats

Today's Range
$54.89
$57.26
50-Day Range
$53.55
$58.73
52-Week Range
$52.51
$71.52
Volume
29 shs
Average Volume
647 shs
Market Capitalization
N/A
P/E Ratio
7.14
Dividend Yield
3.14%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.

Novozymes A/S Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
1st Percentile Overall Score

NVZMF MarketRank™: 

Novozymes A/S scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Novozymes A/S.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Novozymes A/S is 7.14, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.78.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Novozymes A/S is 7.14, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 103.78.

  • Read more about Novozymes A/S's valuation and earnings.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Novozymes A/S has a short interest ratio ("days to cover") of 1266, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Novozymes A/S has recently increased by 0.34%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Novozymes A/S has a dividend yield of 0.72%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Novozymes A/S does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Novozymes A/S is 22.44%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Novozymes A/S's dividend.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Novozymes A/S has a short interest ratio ("days to cover") of 1266, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Novozymes A/S has recently increased by 0.34%, indicating that investor sentiment is decreasing.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Novozymes A/S this week, compared to 0 articles on an average week.
Receive NVZMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter.

NVZMF Stock News Headlines

Novonesis A/S (NVZMF) Q3 2024 Earnings Call Transcript
Why Buffett and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
Novozymes A/S (NVZMF) Q2 2024 Earnings Call Transcript
Novonesis A/S Series B
Novozymes A/S (NZM2.BE)
See More Headlines

NVZMF Stock Analysis - Frequently Asked Questions

Novozymes A/S's stock was trading at $54.86 on January 1st, 2025. Since then, NVZMF stock has increased by 4.4% and is now trading at $57.26.
View the best growth stocks for 2025 here
.

Novozymes A/S (OTCMKTS:NVZMF) posted its quarterly earnings results on Wednesday, April, 20th. The biotechnology company reported $0.37 EPS for the quarter, missing the consensus estimate of $2.43 by $2.06.

Shares of NVZMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
4/20/2016
Today
2/24/2025
Next Earnings (Estimated)
5/01/2025

Industry, Sector and Symbol

Industry
Specialty Chemicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:NVZMF
Fax
N/A
Employees
10,452
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (OTCMKTS:NVZMF) was last updated on 2/24/2025 by MarketBeat.com Staff
From Our Partners